Review Article Open Access
Volume 2 | Issue 2 | DOI: https://doi.org/10.33696/immunology.1.020
Multiple Roles of the Interleukin IL-17 Members in Breast Cancer and Beyond
Stephane Potteaux1,2,*, Jacqueline Lehmann-Che1, Armand Bensussan1, Richard Le Naour2, Yacine Merrouche2,3
- 1Unité Inserm U976 (Immunologie humaine, Pathopysiologie, Immunothérapie); Hôpital Saint-Louis, 1 rue Claude Vellefaux, 75010 Paris, France
- 2IRMAIC, EA7509, Université Reims-Champagne-Ardenne, 51 rue Cognacq-Jay, 51095 Reims CEDEX, France
- 3Institut Godinot, 1 rue du Général Koenig, 51100 Reims, France
Corresponding Author
Stephane Potteaux, stephane.potteaux@inserm.fr
Received Date: January 22, 2020
Accepted Date: February 21, 2020
Potteaux S, Lehmann-Che J, Bensussan A, Le Naour R, Merrouche Y. Multiple Roles of the Interleukin IL-17 Members in Breast Cancer and Beyond. J Cell Immunol. 2020; 2(2): 55-64.
Copyright: © 2020 Potteaux S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Interleukin-17 (IL-17) family proteins are involved in the control of infections. When unrestrained, these cytokines contribute to the development of chronic inflammatory diseases. The IL-17 family contains 6 members: IL-17A to F. In this review, we outline the current knowledge on the roles of each IL-17 member on breast cancer.
Keywords
IL-17, Breast tumor, Microenvironment, Cytokines, Stroma, Immune cells, Inflammation
Recommended Articles
The Nature of Radiation-induced Inherited Recessive Gene Mutations in Drosophila Melanogaster
The nature of gene mutations induced by ionizing radiation in germ cells and transmitted to offspring remains one of the most important problems in radiation genetics of higher eukaryotes. The data accumulated in this field were obtained by different authors under different experimental conditions which does not give a complete insight about the nature of radiation-induced inherited mutations at different genome levels (chromosome, gene, DNA).
Karyotypic Profile of Chronic Myeloid Leukemia in Patients Diagnosed at Tertiary Level in Afghanistan
Balanced translocation resulting in fusion of the Abelson gene (ABL1) from chromosome 9q34 with the breakpoint cluster region (BCR) gene on chromosome 22q11.2 is the pathognomonic molecular driver of CML. The resulting BCRABL 1 fusion gene is both the diagnostic as well as therapeutic target of CML. The first agent with tyrosine kinase inhibitor activity that was licenced in 2000 for treatment of CML patients, was Imatinib, gradually followed by multiple agents with higher efficacy.
Escherichia coli Stress, Multi-cellularity, and the Generation of the Quorum Sensing Peptide EDF
Bacterial communication via quorum sensing (QS) molecules, as well as toxin-antitoxin (TA) gene modules located on bacterial chromosomes are well-studied mechanisms. Escherichia coli mazEF is a stress-induced TA system mediating cell death requiring a QS extracellular death factor (EDF), the pentapeptide NNWNN. MazF is an endoribonuclease specific for ACA sites. During adverse conditions, the activated MazF generates a stress induced translation machinery, composed of MazF-processed mRNAs and selective ribosomes that specifically translate these processed mRNAs.
Constitutively Active Death Receptor Induces Apoptosis in Mammalian Cells
Apoptosis is a physiological response in development and homeostasis of metazoans. Apoptosis is triggered during pathological events as a means to renew affected tissues and eliminate cancer cells. The immune system regulates the extrinsic pathway of apoptosis, where signals such as TNFα or displayed ligands on the surface of immune cells trigger signal cascades by death receptors present on targeted cells. Therapeutics, like Doxorubicin, lead to apoptosis successfully.
Commentary on NOBOX Mutations in Premature Ovarian Insufficiency
NOBOX is an ovarian specific transcription factor that plays an important role in follicular growth and survival. Nineteen NOBOX variants have been previously associated with premature ovarian insufficiency (POI). Disease severity in patients with heterozygous and homozygous mutations largely overlap however, hampering genotype-phenotype correlations. We recently reported the first case of biallelic truncating mutations (NM_001080413.3 (NOBOX):c.826C>T, p.(Arg276*) and NM_001080413.3(NOBOX):c.1421del, p.(Gly474Alafs*76)) of NOBOX in two Belgian sisters with POI.